Add To Watchlist
Share URL
About The Company
CEO
Mr. Nazmul Hassan
Market Cap
490.01 Million GBp
Sector
Healthcare
Website
https://www.beximcopharma.comDescription
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh.
Read More
Overview
Value
24
Growth
53
Health
31
Management
13
Analyst Opinion
71
Total
38
All Scores Out Of 100
Best Features
- Has a low level of debt
- Has a history of share buybacks
- Price-to-earnings ratio of 5.1 is lower than the market average (19.6x)
- Liked by analysts 0
Risk Factors
- Earnings have declined recently
- No margin of safety at their current market price
Market Peers
BXP.L
Key Figures
PE Ratio (TTM)
5.13
Margin Of Safety (DCF)
-98.69%
Revenue Growth (5 Year Average)
15.03%
Ratings Consensus
Buy
Share Buybacks
0.01%
Dividend Yeild (TTM)
0.03%
Valuation
Value Score
24
- ✔ Price-to-earnings ratio of 5.1 is lower than the market average (19.6x)
- ✘ Estimated intrinsic-value of 641.35 undefined GBp is lower than current price ( 50.00 GBp)
- ✘ Free-cashflow-yeild of 0.02% is worse than the market average (4.7%)
- ✘ Margin-of-safety of -98.69% is worse than the market average (17.95%)
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 9.2 GBp ✘
Current Price: 49 GBp
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
5.13x
Free Cashflow Yeild
0.02%
PE/Earnings Growth
N/A
Price/Book
104.29x
Growth
Growth Score
53
- ✔ 5 Year Average Revenue growth of 15.03% is higher than the market average (10.97%)
- ✔ 5 Year Average Earnings growth of 15.94% is higher than the market average (14.48%)
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of 6.05% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
15.03%
Earnings Growth
15.94%
Cashflow Growth
6.05%
Health
Health Score
31
Altman Z Score
1.61
Piostroski Score
4.00
Debt/Equity
N/Ax
Current Assets/Liabilities
1.60x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.67x
Management
Management Score
13
- ✔ Has a history of returning value to shareholders through stock buybacks
- ✔ Has returned higher dividends when earnings have risen
- ✘ Return-on-capital-employed of N/A is lower than the market average (10%)
- ✘ Has repurchased shares when overvalued
- ✘ Return-on-equity of N/A is lower than the market average (15%)
Average Buybacks/Dilution
0.01%
Recent Buybacks/Dilution
N/A
5 Year Price Volitility
38.70%
Return On Assets
N/A
Return On Capital Employed
N/A
Return On Equity
N/A
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
71
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Beximco Pharmaceuticals Limited
Currency
GBp
Beta
0.755989
Vol Avg
49433
Ceo
Mr. Nazmul Hassan
Cik
Cusip
Exchange
London Stock Exchange
Full Time Employees
5500
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Ipo Date
2020-12-15
Address
19 Dhanmondi R/A
City
Dhaka
State
Country
BD
Zip
1205
Phone
880 2 5861 1001
All financial data provided by FMP